IPIX is thorough. The long wait for pre-clinical data should hopefully propel the company into expedited trials for Covid. The super positive fact is that now Brilacidin is now adding viral indicationS to its arsenal. Plus the fact antibiotic resistance is gaining steam helps.
News 
Market Data 
Discover 
